JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB254939

Anti-USP35抗体

Anti-USP35 antibody

Be the first to review this product! Submit a review

|

(5 Publications)

Rabbit Polyclonal USP35 antibody. Suitable for IHC-P, ICC/IF and reacts with Human samples. Cited in 5 publications. Immunogen corresponding to Recombinant Fragment Protein within Human USP35 aa 600-700.

查看别名

KIAA1372, USP34, USP35, Ubiquitin carboxyl-terminal hydrolase 35, Deubiquitinating enzyme 35, Ubiquitin thioesterase 35, Ubiquitin-specific-processing protease 35

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-USP35 antibody (AB254939)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-USP35 antibody (AB254939)

Paraffin-embedded human skeletal muscle tissue stained for USP35 using ab254939 at 1/500 dilution in immunohistochemical analysis.

Immunocytochemistry/ Immunofluorescence - Anti-USP35 antibody (AB254939)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-USP35 antibody (AB254939)

PFA fixed, Triton X-100 permeabilized HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling USP35 using ab254939 at 4µg/ml (green) in ICC/IF.

关键信息

宿主种属

Rabbit

克隆

Polyclonal

亚型

IgG

不含载体蛋白

No

反应种属

Human

应用

IHC-P, ICC/IF

applications

免疫原

Recombinant Fragment Protein within Human USP35 aa 600-700. The exact immunogen used to generate this antibody is proprietary information.

Q9P2H5

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500 - 1/1000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "0.25-2 µg/mL", "ICCIF-species-notes": "<p>Fixation/Permeabilization: PFA/Triton X-100.</p>" } } }

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Immunogen
存储溶液
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine)
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

USP35 also known as Ubiquitin Specific Peptidase 35 is an enzyme involved in the removal of ubiquitin from ubiquitinated proteins. It functions critically in protein degradation by interacting with the ubiquitin-proteasome system. The molecular weight of USP35 is around 119 kDa. USP35 is expressed in multiple tissues including the brain heart and testis indicating a potential for various biological functions in different organ systems.
Biological function summary

USP35 plays a role in regulating protein stability and turnover. As part of deubiquitinating enzymes (DUBs) it helps reverse the ubiquitination process that marks proteins for degradation. It contributes to maintaining protein homeostasis which is important for cell function and survival. USP35 may function as part of larger protein complexes although specific complexes have not been definitively described. Its regulatory role can impact cellular processes significantly.

Pathways

The ubiquitin-proteasome pathway involves USP35 in maintaining protein balance by removing ubiquitin chains. USP35 interacts with other DUBs as well as the proteasome system itself. It is also associated with the ER-associated degradation (ERAD) pathway which controls protein quality in the endoplasmic reticulum. USP35 interacts closely with proteins like HRD1 which is another E3 ubiquitin ligase involved in ERAD highlighting the interconnected nature of protein regulation pathways.

USP35 shows a connection to neurodegenerative disorders such as Parkinson’s disease. Dysregulation of ubiquitin-related processes can lead to an accumulation of misfolded proteins contributing to disease pathogenesis. USP35 may also have a role in cancer where its dysfunction could influence the stability of proteins that control cell growth and apoptosis. Interaction with proteins such as p53 which regulates cell cycle and apoptosis emphasizes the importance of USP35 in maintaining cellular health and preventing disease progression.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Deubiquitinase that plays a role in different processes including cell cycle regulation, mitophagy or endoplasmic reticulum stress (PubMed : 26348204, PubMed : 29449677, PubMed : 37004621). Inhibits TNFalpha-induced NF-kappa-B activation through stabilizing TNIP2 protein via deubiquitination (PubMed : 26348204). Plays an essential role during mitosis by deubiquitinating and thereby regulating the levels of Aurora B/AURKB protein (PubMed : 29449677). In addition, regulates the protein levels of other key component of the chromosomal passenger complex (CPC) such as survivin/BIRC5 or Borealin/CDCA8 by enhancing their stability (PubMed : 34438346). Regulates the degradation of mitochondria through the process of autophagy termed mitophagy (PubMed : 25915564).
See full target information USP35

文献 (5)

Recent publications for all applications. Explore the full list and refine your search

Cell death & disease 16:564 PubMed40715045

2025

The deubiquitinase USP24 suppresses ferroptosis in triple-negative breast cancer by stabilizing DHODH protein.

Applications

Unspecified application

Species

Unspecified reactive species

Li Yang,Xiaoqin An,Shangzhu Yang,Xiaowen Lin,Ziyuan Chen,Qian Xue,Xi Chen,Yuan Wang,Ding Yan,Shirui Chen,Yuqing Fan,Daolin Tang,Wenfeng Yu,Jinbao Liu,Xin Chen

Nature communications 15:210 PubMed38172207

2024

Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Feiyang Ma,Pei-Suen Tsou,Mehrnaz Gharaee-Kermani,Olesya Plazyo,Xianying Xing,Joseph Kirma,Rachael Wasikowski,Grace A Hile,Paul W Harms,Yanyun Jiang,Enze Xing,Mio Nakamura,Danielle Ochocki,William D Brodie,Shiv Pillai,Emanual Maverakis,Matteo Pellegrini,Robert L Modlin,John Varga,Lam C Tsoi,Robert Lafyatis,J Michelle Kahlenberg,Allison C Billi,Dinesh Khanna,Johann E Gudjonsson

Cell death discovery 9:421 PubMed37993419

2023

USP35 promotes HCC development by stabilizing ABHD17C and activating the PI3K/AKT signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Linpei Wang,Jiawei Wang,Xiaoqiu Ma,Guomin Ju,Chunfeng Shi,Wei Wang,Jian Wu

International journal of oncology 63: PubMed37594129

2023

USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination‑mediated degradation.

Applications

Unspecified application

Species

Unspecified reactive species

Tao Lv,Bo Zhang,Chenghao Jiang,Qiwen Zeng,Jiayin Yang,Yongjie Zhou

Journal of inflammation research 15:3065-3082 PubMed35637872

2022

is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma.

Applications

Unspecified application

Species

Unspecified reactive species

Qian Zhang,Yuan-Jie Liu,Jie-Pin Li,Shu-Hong Zeng,Hui Shen,Mei Han,Shun Guo,Shen-Lin Liu,Xi Zou
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com